Senators Question Pfizer, Mylan, Others on Drug Pricing

Jun 08, 2016

Bloomberg

U.S. senators asked five drugmakers to explain increases in the price of naloxone, a drug that is used to reverse the effects of opioids, according to a Bloomberg article. The senators also want to know what the companies are doing to preserve access to the drug, which hospitals have said they’ve had trouble obtaining.

Senators Susan Collins, a Maine Republican, and Claire McCaskill, a Missouri Democrat, wrote to Pfizer Inc., Mylan NV, Amphastar Pharmaceuticals Inc., Adapt Pharma Inc. and Kaleo Inc., asking them to explain price changes for naloxone, the story said. They cited a report in Politico that at least one version of the drug has risen in price by as much as 17-fold in the last two years.

Read the Bloomberg article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments